Pre-clinical reports describe increased follicle size, prolonged anagen phase, and improved scalp vascularization in animal studies and ex-vivo follicle cultures [8]
GLP-1 receptor agonists in either form share the class boxed warning for thyroid C-cell tumor risk observed in rodent studies
Wegovy is not recommended for anyone with a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer), or for people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG , Ajani JA, Hofstetter WL, Rashid A
Where should I go if I am still comparing
Patients should also be aware that GLP-1 agonists may increase the risk of gallbladder disease, which can present with right upper quadrant pain and may contribute to pancreatitis risk